ENvue Medical (FEED) EBITDA (2014 - 2026)

ENvue Medical (FEED) has 13 years of EBITDA data on file, last reported at -$3.7 million in Q1 2026.

• On a quarterly basis, EBITDA fell 100.38% year-over-year to -$3.7 million in Q1 2026; TTM through Mar 2026 was -$24.7 million, a 408.59% decrease from a year earlier, with the FY2025 full-year figure at -$22.9 million, down 539.0% from the prior year.
• EBITDA for Q1 2026 stood at -$3.7 million, up from -$14.8 million in the prior quarter.
• Over the last five years, EBITDA for FEED reached as high as -$568000.0 in Q1 2024 and fell as low as -$14.8 million in Q4 2025.
• Historically, EBITDA has averaged -$2.3 million across 5 years, with a median of -$1.1 million in 2022.
• Across the five-year window, EBITDA jumped 58.9% in 2023 and slumped 981.31% in 2025, its largest moves.
• Year by year, EBITDA stood at -$1.7 million in 2022, then soared by 58.9% to -$702000.0 in 2023, then slumped by 95.16% to -$1.4 million in 2024, then slumped by 981.31% to -$14.8 million in 2025, then jumped by 74.95% to -$3.7 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$3.7 million in Q1 2026, -$14.8 million in Q4 2025, and -$2.2 million in Q3 2025.